Market Overview
The temozolomide market continues to hold clinical importance as a standard oral alkylating agent used in treating glioblastoma multiforme, anaplastic astrocytoma, and selected advanced melanoma cases. Rising global incidence of central nervous system tumors, improved diagnostic imaging, and expanding oncology infrastructure support steady prescription volumes. Patent...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek